Faculty

Mario Salvi, M.D.

Milan, Italy

Dr. Salvi graduated in Medicine and trained in Endocrinology in Parma, Italy. He carried out post-doc research projects at McGill University in 1985-91 with specific focus on the pathogenesis of Graves’ disease and orbitopathy. He continued his work in Parma until 2001 and from 2002 at the University of Milan. He is heading a Graves’ Orbitopathy Center of the Fondazione IRCCS Cà Granda, Milan. Since 2003 he has pioneered immunotherapy and has been carrying out clinical studies with rituximab, the anti-BAFF belimumab, the anti-IGF-1 receptor antibody teprotumumab, and the anti-Il-6 receptor antibody tocilizumab in Graves’ orbitopathy, in addition to multicenter trials carried out within EUGOGO. He has contributed to the book: “Graves’ Orbitopathy: a multidisciplinary approach” edited by EUGOGO, and is co-authoring the ATA/ETA guidelines on Graves’ orbitopathy. He has published more than 190 papers (H-Index 44) and gave more than 200 scientific communications and invited lectures at international meetings.

Login

Insert email and password to join the platform

Forgot Password or Register now

Thyroidea - International Summit on Thyroid Topics

Register

To complete your registration use the email where you received the invitation, fill this form and setup your password.

E-mail address

First Name

Last Name

Country

Setup your password

Password

Repeat Password

I declare that I am a Healtcare Professional

I have read and agree to the information notice pursuant to art. 13 of Regulation EU 2016/679 of the European Parliament and of the Council of 27 April 2016 (General Data Protection Regulation, so-called "GDPR") as detailed in the link below.
https://ibsathyroidea.com/privacy-policy/

To receive institutional communications and scientific and / or technical information do you consent to share your information?

I give my consent

I don't give my consent

Already registered? Login

Recover password

Type the email address you used for the registration. You will receive an email with the istruction to set a new password.

Back to Login

Set new password

Please choose a new password for your account.

Back to Login